Home » Market News » DirectorsTalk Highlights » Boy allergic to his own tears could die at any time from his allergies
Allergy therapeutics plc

Boy allergic to his own tears could die at any time from his allergies

A nine-month-old baby suffers with regular rashes and swelling as he has at least 50 allergies. Riley Kinsey’s family live in fear that he could pick up an allergic reaction that becomes life-threatening. He is allergic to inflatables, apples and he can’t even cry as his own tears will trigger a reaction which leaves his face swollen to double its normal size.

Allergy Therapeutics (LON:AGY) is a visionary immunology business with specialist experience in the research and development of allergy treatments. We have a well-established commercial presence in Europe and are focused on the US market.

We specialise in the diagnosis and treatment of allergy. We mainly sell our products in European countries and our pipeline of products in clinical development includes vaccines for grass, tree and house dust mite, as well as a peanut allergy vaccine in pre-clinical development.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.